Oxygen Saturation Alarms in the Neonatal Intensive Care Unit

Status Completed

Clinical Trial Summary

Infants will be observed in the neonatal intensive care unit for 4 hours. The observer will note the timing of oxygen saturation alarms, staff response, and interrupted staff activities.

Clinical Trial Description

False alarms may be particularly prevalent in the neonatal intensive care unit (NICU) where uncontrolled motion of infants can intensify the problem. The performance of pulse oximeters is of particular importance in the NICU because of the danger that both hyperoxemia and hypoxemia pose to newborns; hyperoxemia can lead to chronic lung disease or retinopathy of prematurity, and hypoxemia depresses spontaneous ventilation. High false alarm rates contribute to the problem of noise in the NICU. They also have the potential to endanger patients if clinicians become inured to the continual alarms and ignore some that may be clinically relevant. There have been few studies on the utility of pulse oximeter alarms in the NICU, particularly with the new-generation technology. This study will build on the small body of existing literature on alarm rates in new-generation pulse oximeters in neonates and provide details about the relationship of the alarms to clinical interventions.

This is an observational study of 50 infants at three hospitals in the United States. The observer will be an experienced nurse with comprehensive training to ensure consistency. The infants and clinical staff will be observed for four hours continuously. Observers will note the timing of alarms, response, interrupted clinical staff activities, and any clinical interventions, and timing of interventions. Clinical staff will also be questioned on whether the alarm was consistent with a desaturation event. Infant characteristics may affect the frequency of alarms. Data collected will include age, gender, weight, ethnicity, diagnosis, and medications.

This study will evaluate the proportion of nuisance alarms relative to the proportion of clinically relevant alarms. It will also evaluate the differences in alarm frequencies across infant characteristics and characterize nurse activities interrupted by the alarms. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Hypoxemia

Clinical Trial Details

NCT number	NCT01085539
Study type	Observational
Source	Medtronic - MITG
Contact
Status	Completed
Phase	N/A
Start date	January 2010
Completion date	June 2010

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT03628560` - Alternate Methodology of Pulse Oximeter Validation	N/A
Completed	`NCT02866578` - Open Lung Protective Ventilation in Cardiac Surgery	N/A
Recruiting	`NCT06139081` - Oxygen Delivery Methods of Nasal Catheter on the Incidence of Hypoxemia in Patients With Painless Gastroscopy	N/A
Not yet recruiting	`NCT05964309` - Pre-oxygenation in Sitting Position and Oxygen Reserve Index	N/A
Completed	`NCT00675415` - Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?	N/A
Completed	`NCT00740220` - Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation	N/A
Completed	`NCT04557605` - Effects of a Face Mask on Oxygenation During Exercise	N/A
Active, not recruiting	`NCT05479929` - Work of Breathing Assessment in Triage Scale
Recruiting	`NCT05422430` - Rebreathing-induced Hypoxia and Glucose Levels	N/A
Recruiting	`NCT03009643` - Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery	N/A
Completed	`NCT01949012` - Capnography Monitoring During Intravenous Conscious Sedation Sedation With Midazolam for Oral Surgery	N/A
Completed	`NCT01477450` - Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects	N/A
Completed	`NCT01470170` - Regimen of Alfentanil in Propofol Sedative Fibro-bronchoscopy	Phase 4
Recruiting	`NCT06085859` - Anesthesia Endoscope Mask is Applied to Sedation Upper Gastrointestinal Endoscopic Diagnosis and Treatment	N/A
Recruiting	`NCT03969615` - SuperNO2VA™ and General Anesthesia Postoperative Care	N/A
Completed	`NCT02554110` - Peripheral Nerve Stimulation to Reduce Hypoxic Events	N/A
Completed	`NCT04998253` - Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2	Early Phase 1
Completed	`NCT04566419` - poStoperative Anesthesia Care: Facial Mask vs Hfnc and Thoracic Ultrasound for Reduction of Atelectasis Incidence	N/A
Recruiting	`NCT04079465` - Automated Oxygen Control by O2matic to Patients Admitted With Acute Hypoxemia	N/A
Recruiting	`NCT06022523` - Accuracy of Pulse Oximeters With Profound Hypoxia	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.